Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.

Deep G, Jain AK, Ramteke A, Ting H, Vijendra KC, Gangar SC, Agarwal C, Agarwal R.

Mol Cancer. 2014 Feb 24;13:37. doi: 10.1186/1476-4598-13-37.

2.

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.

Zhou Q, Yan B, Hu X, Li XB, Zhang J, Fang J.

Mol Cancer Ther. 2009 Jun;8(6):1684-91. doi: 10.1158/1535-7163.MCT-09-0191. Epub 2009 Jun 9.

3.

Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.

Deep G, Gangar SC, Agarwal C, Agarwal R.

Cancer Prev Res (Phila). 2011 Aug;4(8):1222-32. doi: 10.1158/1940-6207.CAPR-10-0370. Epub 2011 May 5.

4.

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.

Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2485-90. doi: 10.1073/pnas.0908133107. Epub 2010 Jan 13.

5.

Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.

Shukla S, Sharma H, Abbas A, MacLennan GT, Fu P, Danielpour D, Gupta S.

PLoS One. 2013;8(1):e53527. doi: 10.1371/journal.pone.0053527. Epub 2013 Jan 7.

6.

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

Putzke AP, Ventura AP, Bailey AM, Akture C, Opoku-Ansah J, Celiktaş M, Hwang MS, Darling DS, Coleman IM, Nelson PS, Nguyen HM, Corey E, Tewari M, Morrissey C, Vessella RL, Knudsen BS.

Am J Pathol. 2011 Jul;179(1):400-10. doi: 10.1016/j.ajpath.2011.03.028. Epub 2011 May 4.

7.

Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo.

Zhang K, Zhang S, Jiao X, Wang H, Zhang D, Niu Z, Shen Y, Lv L, Zhou Y.

Med Oncol. 2011 Dec;28(4):1089-100. doi: 10.1007/s12032-010-9652-7. Epub 2010 Aug 21.

PMID:
20730573
8.

Type I collagen down-regulates E-cadherin expression by increasing PI3KCA in cancer cells.

Cheng JC, Leung PC.

Cancer Lett. 2011 May 28;304(2):107-16. doi: 10.1016/j.canlet.2011.02.008. Epub 2011 Mar 4.

PMID:
21377268
9.

AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation.

Wang M, Zhao F, Li S, Chang AK, Jia Z, Chen Y, Xu F, Pan H, Wu H.

PLoS One. 2013 Jun 7;8(6):e65556. doi: 10.1371/journal.pone.0065556. Print 2013.

10.

The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.

Yee DS, Tang Y, Li X, Liu Z, Guo Y, Ghaffar S, McQueen P, Atreya D, Xie J, Simoneau AR, Hoang BH, Zi X.

Mol Cancer. 2010 Jun 23;9:162. doi: 10.1186/1476-4598-9-162.

12.

Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.

Lan X, Lu G, Yuan C, Mao S, Jiang W, Chen Y, Jin X, Xia Q.

J Cancer Res Clin Oncol. 2016 Jan;142(1):177-85. doi: 10.1007/s00432-015-2020-4. Epub 2015 Jul 24.

PMID:
26206483
13.

Parathyroid hormone related-protein promotes epithelial-to-mesenchymal transition in prostate cancer.

Ongkeko WM, Burton D, Kiang A, Abhold E, Kuo SZ, Rahimy E, Yang M, Hoffman RM, Wang-Rodriguez J, Deftos LJ.

PLoS One. 2014 Jan 22;9(1):e85803. doi: 10.1371/journal.pone.0085803. eCollection 2014.

14.

Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.

Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A.

Cancer Res. 2005 Dec 15;65(24):11649-57.

15.

Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.

Wang C, Wang L, Su B, Lu N, Song J, Yang X, Fu W, Tan W, Han B.

Prostate. 2014 May;74(7):689-701. doi: 10.1002/pros.22787. Epub 2014 Mar 12.

PMID:
24619958
16.

Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, Chen JF, Zhang EB, De W, Wang ZX.

Mol Cancer. 2014 Mar 21;13:68. doi: 10.1186/1476-4598-13-68.

17.

SNAI1 is involved in the proliferation and migration of glioblastoma cells.

Han SP, Kim JH, Han ME, Sim HE, Kim KS, Yoon S, Baek SY, Kim BS, Oh SO.

Cell Mol Neurobiol. 2011 Apr;31(3):489-96. doi: 10.1007/s10571-010-9643-4. Epub 2011 Jan 12.

PMID:
21225336
18.

Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J.

Prostate. 2015 Jun 15;75(9):957-68. doi: 10.1002/pros.22978. Epub 2015 Feb 25.

PMID:
25728945
19.

SALL4, a novel marker for human gastric carcinogenesis and metastasis.

Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang M, Zhang X, Yang T, Cai J, Yan Y, Mao F, Zhu W, Shao Q, Qian H, Xu W.

Oncogene. 2014 Nov 27;33(48):5491-500. doi: 10.1038/onc.2013.495. Epub 2013 Nov 25.

PMID:
24276240
20.

Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.

Windus LC, Glover TT, Avery VM.

Mol Cancer. 2013 Sep 30;12(1):112. doi: 10.1186/1476-4598-12-112. Erratum in: Mol Cancer. 2014;13():188.

Items per page

Supplemental Content

Write to the Help Desk